Literature DB >> 28197077

Commentary: Genome-wide association study identifies 74 loci associated with educational attainment.

Félix Hernández1, Jesús Ávila1.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; SNP; educational attainment; tau; tauopathies

Year:  2017        PMID: 28197077      PMCID: PMC5281599          DOI: 10.3389/fnmol.2017.00023

Source DB:  PubMed          Journal:  Front Mol Neurosci        ISSN: 1662-5099            Impact factor:   5.639


× No keyword cloud information.
It is generally assumed that social and other environmental factors like poverty are involved in educational attainment. However, a recently published genome-wide association study (GWAS) for educational attainment of 293,723 individuals (Okbay et al., 2016) identified 74 loci associated with the number of years of schooling completed, with eight of them showing the highest association. One of these genes showing a single-nucleotide polymorphism (SNP) linked to educational attainment was located on chromosome 17. The SNP was rs192818565 (dbSNP ID: has merged into rs62056842 T/G) in position chr17:45914149 (according to GRCh38.p7 assembly of human genome), located within the first intron on the MAPT gene (microtubule associated protein tau, Figure 1A; http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=62056842).
Figure 1

MAPT gene. A single tau gene located on the human chromosome 17 is transcribed into the corresponding nuclear RNA that, by alternative splicing, yields several tau mRNAs. (A) Exons are labeled in red numbers. Sth indicates the existence of a DNA sequence encoding the protein saithoin within the intron between exons 9 and 10. ncRNAs MAPT-AS1, MAPT-IT1 and likely LOC105371800 are shown. Light blue boxes: SNP present in MAPT gene; purple boxes: SNP labeled as “probable pathogenic” or “pathogenic”; red and orange boxes: SNPs that genetic association studies have linked to a strong risk to major diseases (Parkinson disease –rs17563986- and progressive supranuclear palsy –rs242557-). Some SNPs used to describe MAPT haplotypes are flanking the SNP here commented on (rs62056842) and are located within that first intron (rs1467967 and rs242557). (B) Allele frequencies of SNP rs192818565 in diverse human populations (rs544990728 in 1000 genomes data base). Data and images have been taken from https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/.

MAPT gene. A single tau gene located on the human chromosome 17 is transcribed into the corresponding nuclear RNA that, by alternative splicing, yields several tau mRNAs. (A) Exons are labeled in red numbers. Sth indicates the existence of a DNA sequence encoding the protein saithoin within the intron between exons 9 and 10. ncRNAs MAPT-AS1, MAPT-IT1 and likely LOC105371800 are shown. Light blue boxes: SNP present in MAPT gene; purple boxes: SNP labeled as “probable pathogenic” or “pathogenic”; red and orange boxes: SNPs that genetic association studies have linked to a strong risk to major diseases (Parkinson diseasers17563986- and progressive supranuclear palsyrs242557-). Some SNPs used to describe MAPT haplotypes are flanking the SNP here commented on (rs62056842) and are located within that first intron (rs1467967 and rs242557). (B) Allele frequencies of SNP rs192818565 in diverse human populations (rs544990728 in 1000 genomes data base). Data and images have been taken from https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/. The human tau gene is located on chromosome 17: 45,894,382–46,028,334, and it contains 16 exons that by historical reasons have been numbered as shown in Figure 1A. Tau is mainly expressed in neurons, and by alternative splicing of exons 2, 3, and 10 yields different mRNA species in the central nervous system (Andreadis, 2005). Alternative splicing of exon 10 produces tau isoforms with either three (3R-tau, lacking exon 10) or four (4R–tau, including exon 10) tubulin/microtubule binding repeats. The locus where MAPT gene is present has been divided into two haplotypes, H1 and H2. Haplotype H2 is inverted with respect to H1. The inversion encompasses a number of genes (CRHR1, IMP5, MAPT, and NSF) and the absence of recombination between them has resulted in both haplotypes defined among other marks by 8 SNP (for a review see Caffrey and Wade-Martins, 2007). Non-inverted H1 haplotypes are more susceptibility to tauopathies and its promoter is more efficient at transcription level compared with H2 promoter (Kwok et al., 2004). Tau protein is altered in many diseases, from Alzheimer's disease (AD) to Parkinson's disease (PD) and, as has been recently described, Huntington's disease (Avila et al., 2004; Fernández-Nogales et al., 2014; Iqbal et al., 2016). Tau missense mutations have been described in FTDP-17 while in other tauopathies tau levels or the 3R/4R-tau ratio are altered. While SNPs are roughly homogeneously distributed throughout the gene (Figure 1A, light blue boxes), clinical association studies have shown that SNPs labeled as “probably pathogenic” or “pathogenic” are mainly located at the 3′-end of the gene, where the coding exons are located (Figure 1A, purple boxes, http://www.ncbi.nlm.nih.gov/projects/SNP/). Conversely, the first intron where the SNP linked to educational attainment was located, has few of those. Interestingly, genetic association studies have found associations between SNPs in the first intron (close to rs62056842; Figure 1A, red and orange boxes) and a strong associated risk to major diseases. Furthermore, two SNPs used to describe MAPT haplotypes are flanking the above mentioned SNP and are located within that first intron (rs1467967-position chr17:45908813- and rs242557 –position chr17:45942346-) (Myers et al., 2007). Few studies have focused on intron 0. As in many eukaryotic genes (Bradnam and Korf, 2008), the first intron is the longest one found in the MAPT gene likely because it harbors cis regulatory sequences (Chorev and Carmel, 2012). MAPT promoter presents two main characteristic: absence of TATA and CAAT boxes and a big G+C content (Gao et al., 2005). Thus, methylation of CpG islands present in exon and intron 0 can modulate tau expression likely altering accessibility to binding factors and transcription initiation factors (Caillet-Boudin et al., 2015). With these ideas in mind, it is tempting to speculate that rs62056842 SNP might affect that regulatory system. In fact CpG island close to rs242557 SNP is hypomethylated in PSP (Huin et al., 2016) and H1 haplotype increases risk for tauopathy via differential methylation (Li et al., 2014). In addition, taking into account that this first intron harbors several ncRNA it can be hypothesized that the above mentioned SNP could alter some of them. MAPT-AS1 is an 840 bp long ncRNA transcribed from the anti-sense strand of the MAPT which has an inhibitory effect on MAPT promoter activity (Coupland et al., 2016). Interestingly, a significant decrease in MAPT-AS1 expression has been observed in PD (Coupland et al., 2016). Thus, it might be suggested that considering that the rs62056842 is close to the MAPT-AS1 promoter, its expression can be modulated by that particular SNP. The study here commented on by Okbay et al. has only examined people of European ancestry and it is unclear whether the observed results apply to those with roots in other regions (Figure 1B). In fact, the 1000 genomes project (www.ncbi.nlm.nih.gov/variation/tools/1000genomes/) shows that, although rs62056842 presents an allele frequency of T = 0.9147 and G = 0.0853, being the allele T the one associated with higher values of educational attainment in the meta-analysis carried out by the authors, that frequency shows great variation and, for example, it is not present in people from Africa or China where T = 1. Overall, this study shows the importance of tau protein not only in learning, as different animal models have demonstrated, but also in educational attainment, being one of the genetic factors involved.

Author contributions

All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  15 in total

Review 1.  Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases.

Authors:  Athena Andreadis
Journal:  Biochim Biophys Acta       Date:  2005-01-03

2.  Huntington's disease is a four-repeat tauopathy with tau nuclear rods.

Authors:  Marta Fernández-Nogales; Jorge R Cabrera; María Santos-Galindo; Jeroen J M Hoozemans; Isidro Ferrer; Annemieke J M Rozemuller; Félix Hernández; Jesús Avila; José J Lucas
Journal:  Nat Med       Date:  2014-07-20       Impact factor: 53.440

Review 3.  Tau and neurodegenerative disease: the story so far.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Nat Rev Neurol       Date:  2015-12-04       Impact factor: 42.937

Review 4.  Role of tau protein in both physiological and pathological conditions.

Authors:  Jesus Avila; Jose J Lucas; Mar Perez; Felix Hernandez
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

5.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

Review 6.  Regulation of human MAPT gene expression.

Authors:  Marie-Laure Caillet-Boudin; Luc Buée; Nicolas Sergeant; Bruno Lefebvre
Journal:  Mol Neurodegener       Date:  2015-07-14       Impact factor: 14.195

7.  An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.

Authors:  Yun Li; Jason A Chen; Renee L Sears; Fuying Gao; Eric D Klein; Anna Karydas; Michael D Geschwind; Howard J Rosen; Adam L Boxer; Weilong Guo; Matteo Pellegrini; Steve Horvath; Bruce L Miller; Daniel H Geschwind; Giovanni Coppola
Journal:  PLoS Genet       Date:  2014-03-06       Impact factor: 5.917

8.  Longer first introns are a general property of eukaryotic gene structure.

Authors:  Keith R Bradnam; Ian Korf
Journal:  PLoS One       Date:  2008-08-29       Impact factor: 3.240

9.  Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.

Authors:  Kirsten G Coupland; Woojin S Kim; Glenda M Halliday; Marianne Hallupp; Carol Dobson-Stone; John B J Kwok
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

10.  Genome-wide association study identifies 74 loci associated with educational attainment.

Authors:  Aysu Okbay; Jonathan P Beauchamp; Mark Alan Fontana; James J Lee; Tune H Pers; Cornelius A Rietveld; Patrick Turley; Guo-Bo Chen; Valur Emilsson; S Fleur W Meddens; Sven Oskarsson; Joseph K Pickrell; Kevin Thom; Pascal Timshel; Ronald de Vlaming; Abdel Abdellaoui; Tarunveer S Ahluwalia; Jonas Bacelis; Clemens Baumbach; Gyda Bjornsdottir; Johannes H Brandsma; Maria Pina Concas; Jaime Derringer; Nicholas A Furlotte; Tessel E Galesloot; Giorgia Girotto; Richa Gupta; Leanne M Hall; Sarah E Harris; Edith Hofer; Momoko Horikoshi; Jennifer E Huffman; Kadri Kaasik; Ioanna P Kalafati; Robert Karlsson; Augustine Kong; Jari Lahti; Sven J van der Lee; Christiaan deLeeuw; Penelope A Lind; Karl-Oskar Lindgren; Tian Liu; Massimo Mangino; Jonathan Marten; Evelin Mihailov; Michael B Miller; Peter J van der Most; Christopher Oldmeadow; Antony Payton; Natalia Pervjakova; Wouter J Peyrot; Yong Qian; Olli Raitakari; Rico Rueedi; Erika Salvi; Börge Schmidt; Katharina E Schraut; Jianxin Shi; Albert V Smith; Raymond A Poot; Beate St Pourcain; Alexander Teumer; Gudmar Thorleifsson; Niek Verweij; Dragana Vuckovic; Juergen Wellmann; Harm-Jan Westra; Jingyun Yang; Wei Zhao; Zhihong Zhu; Behrooz Z Alizadeh; Najaf Amin; Andrew Bakshi; Sebastian E Baumeister; Ginevra Biino; Klaus Bønnelykke; Patricia A Boyle; Harry Campbell; Francesco P Cappuccio; Gail Davies; Jan-Emmanuel De Neve; Panos Deloukas; Ilja Demuth; Jun Ding; Peter Eibich; Lewin Eisele; Niina Eklund; David M Evans; Jessica D Faul; Mary F Feitosa; Andreas J Forstner; Ilaria Gandin; Bjarni Gunnarsson; Bjarni V Halldórsson; Tamara B Harris; Andrew C Heath; Lynne J Hocking; Elizabeth G Holliday; Georg Homuth; Michael A Horan; Jouke-Jan Hottenga; Philip L de Jager; Peter K Joshi; Astanand Jugessur; Marika A Kaakinen; Mika Kähönen; Stavroula Kanoni; Liisa Keltigangas-Järvinen; Lambertus A L M Kiemeney; Ivana Kolcic; Seppo Koskinen; Aldi T Kraja; Martin Kroh; Zoltan Kutalik; Antti Latvala; Lenore J Launer; Maël P Lebreton; Douglas F Levinson; Paul Lichtenstein; Peter Lichtner; David C M Liewald; Anu Loukola; Pamela A Madden; Reedik Mägi; Tomi Mäki-Opas; Riccardo E Marioni; Pedro Marques-Vidal; Gerardus A Meddens; George McMahon; Christa Meisinger; Thomas Meitinger; Yusplitri Milaneschi; Lili Milani; Grant W Montgomery; Ronny Myhre; Christopher P Nelson; Dale R Nyholt; William E R Ollier; Aarno Palotie; Lavinia Paternoster; Nancy L Pedersen; Katja E Petrovic; David J Porteous; Katri Räikkönen; Susan M Ring; Antonietta Robino; Olga Rostapshova; Igor Rudan; Aldo Rustichini; Veikko Salomaa; Alan R Sanders; Antti-Pekka Sarin; Helena Schmidt; Rodney J Scott; Blair H Smith; Jennifer A Smith; Jan A Staessen; Elisabeth Steinhagen-Thiessen; Konstantin Strauch; Antonio Terracciano; Martin D Tobin; Sheila Ulivi; Simona Vaccargiu; Lydia Quaye; Frank J A van Rooij; Cristina Venturini; Anna A E Vinkhuyzen; Uwe Völker; Henry Völzke; Judith M Vonk; Diego Vozzi; Johannes Waage; Erin B Ware; Gonneke Willemsen; John R Attia; David A Bennett; Klaus Berger; Lars Bertram; Hans Bisgaard; Dorret I Boomsma; Ingrid B Borecki; Ute Bültmann; Christopher F Chabris; Francesco Cucca; Daniele Cusi; Ian J Deary; George V Dedoussis; Cornelia M van Duijn; Johan G Eriksson; Barbara Franke; Lude Franke; Paolo Gasparini; Pablo V Gejman; Christian Gieger; Hans-Jörgen Grabe; Jacob Gratten; Patrick J F Groenen; Vilmundur Gudnason; Pim van der Harst; Caroline Hayward; David A Hinds; Wolfgang Hoffmann; Elina Hyppönen; William G Iacono; Bo Jacobsson; Marjo-Riitta Järvelin; Karl-Heinz Jöckel; Jaakko Kaprio; Sharon L R Kardia; Terho Lehtimäki; Steven F Lehrer; Patrik K E Magnusson; Nicholas G Martin; Matt McGue; Andres Metspalu; Neil Pendleton; Brenda W J H Penninx; Markus Perola; Nicola Pirastu; Mario Pirastu; Ozren Polasek; Danielle Posthuma; Christine Power; Michael A Province; Nilesh J Samani; David Schlessinger; Reinhold Schmidt; Thorkild I A Sørensen; Tim D Spector; Kari Stefansson; Unnur Thorsteinsdottir; A Roy Thurik; Nicholas J Timpson; Henning Tiemeier; Joyce Y Tung; André G Uitterlinden; Veronique Vitart; Peter Vollenweider; David R Weir; James F Wilson; Alan F Wright; Dalton C Conley; Robert F Krueger; George Davey Smith; Albert Hofman; David I Laibson; Sarah E Medland; Michelle N Meyer; Jian Yang; Magnus Johannesson; Peter M Visscher; Tõnu Esko; Philipp D Koellinger; David Cesarini; Daniel J Benjamin
Journal:  Nature       Date:  2016-05-11       Impact factor: 49.962

View more
  1 in total

Review 1.  Our Working Point of View of Tau Protein.

Authors:  Jesús Avila
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.